Literature DB >> 22226388

[Intravitreal injections: AFSSAPS guide to good practice].

B Bodaghi1, J F Korobelnik, I Cochereau, J Hajjar, F Goebel, N Dumarcet.   

Abstract

Intravitreal injections are very commonly performed in the daily practice of Ophthalmology and become a leading procedure in the management of age-related macular degeneration, diabetic retinopathy, infectious endophthalmitis or retinitis, uveitis and retinal vein occlusions. Based on the comments of a group of experts, including ophthalmologists, pharmacists and hygienists, the French Agency for the Safety of Health Products (AFSSAPS) edited a guide to good practice of intravitreal injections, revisiting those previously published in 2006. The overall experience accumulated during time is a valuable source of information to determine the most appropriate protocol. Therefore, the simplification of the procedure is reasonably proposed even though safety remains a major issue, in order to avoid complications, especially infections.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22226388     DOI: 10.1016/j.jfo.2011.11.005

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  4 in total

Review 1.  A European approach to categorizing medicines for fitness to drive: outcomes of the DRUID project.

Authors:  Silvia Ravera; Susana P Monteiro; Johan Jacob de Gier; Trudy van der Linden; Trinidad Gómez-Talegón; F Javier Alvarez
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

2.  Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti-Vascular Growth Factor Agents in a Nationwide Study in France.

Authors:  Florian Baudin; Eric Benzenine; Anne-Sophie Mariet; Alain M Bron; Vincent Daien; Jean François Korobelnik; Catherine Quantin; Catherine Creuzot-Garcher
Journal:  JAMA Ophthalmol       Date:  2018-12-01       Impact factor: 7.389

Review 3.  Antibioprophylaxis in Prevention of Endophthalmitis in Intravitreal Injection: A Systematic Review and Meta-Analysis.

Authors:  Cédric Benoist d'Azy; Bruno Pereira; Geraldine Naughton; Frédéric Chiambaretta; Frédéric Dutheil
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

4.  Topical azithromycin or ofloxacin for endophthalmitis prophylaxis after intravitreal injection.

Authors:  Pedro Romero-Aroca; Laura Sararols; Lluis Arias; Ricardo P Casaroli-Marano; Francisca Bassaganyas
Journal:  Clin Ophthalmol       Date:  2012-10-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.